13F Data
Security · CUSIP 56565P103

MAPLIGHT THERAPEUTICS INC

COM · institutional ownership from 13F filings
13F holders
74
Shares held
25.9M
Value held
$454.3M
New / sold out
74 / 0
Added / reduced
0 / 0
net +25.9M shares

13F holders by quarter

Q4 2025: 74Q1 2026: 81Q2 2026: 105Q3 2026: 24
Q4 2025Q3 2026

Net shares bought by existing holders

Q4 2025: 25.9MQ1 2026: -1.2MQ2 2026: 1.5MQ3 2026: 147.0K
Q4 2025Q3 2026

Top holders · Q4 2025

ManagerSharesValue% of portfolio
T. Rowe Price Investment Management, Inc.5,598,360$98.3M0.04%
NOVO HOLDINGS A/S3,686,622$64.8M5.03%
FCPM III SERVICES B.V.3,226,400$56.7M7.43%
GOLDMAN SACHS GROUP INC1,937,168$34.0M0.00%
BlackRock, Inc.1,095,514$19.2M0.00%
Nan Fung Group Holdings Ltd971,253$17.1M15.27%
5AM Venture Management, LLC950,011$16.7M5.25%
Sanofi912,041$16.0M5.16%
VANGUARD GROUP INC869,668$15.3M0.00%
Pivotal bioVenture Partners Investment Advisor LLC611,447$10.7M4.15%
64 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest buyers

ManagerChangeShares changeChange %
T. Rowe Price Investment Management, Inc.New+5,598,360–
NOVO HOLDINGS A/SNew+3,686,622–
FCPM III SERVICES B.V.New+3,226,400–
GOLDMAN SACHS GROUP INCNew+1,937,168–
BlackRock, Inc.New+1,095,514–
Nan Fung Group Holdings LtdNew+971,253–
5AM Venture Management, LLCNew+950,011–
SanofiNew+912,041–
VANGUARD GROUP INCNew+869,668–
Pivotal bioVenture Partners Investment Advisor LLCNew+611,447–
64 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sellers

Nothing to show.